Genocea Biosciences CEO William Clark's 2018 pay slips 14% to $1.3M

Genocea Biosciences reports 2018 executive compensation

By ExecPay News

Published: March 29, 2019

Genocea Biosciences reported fiscal year 2018 executive compensation information on March 29, 2019.
In 2018, four executives at Genocea Biosciences received on average a compensation package of $770K, a 14% decrease compared to previous year.
Average pay of disclosed executives at Genocea Biosciences
William Clark, Chief Executive Officer, received $1.3M in total, which decreased by 14% compared to 2017. 45% of Clark's compensation, or $583K, was in option awards. Clark also received $207K in non-equity incentive plan, $515K in salary, as well as $6K in other compensation.
Jessica Baker Fletchner, Chief Scientific Officer, received a compensation package of $734K, which increased by 2% compared to previous year. 47% of the compensation package, or $346K, was in salary.
Eric Hoffman, Former Chief Business Officer, earned $546K in 2018, a 22% decrease compared to previous year.
Pamela Carroll, Senior Vice President, Immuno, Oncology, received $488K in 2018, which increases by 6% compared to 2017.

Related executives

William Clark

Genocea Biosciences

Chief Executive Officer

Jessica Fletchner

Genocea Biosciences

Chief Scientific Officer

Pamela Carroll

Genocea Biosciences

Senior Vice President, Immuno, Oncology

Eric Hoffman

Genocea Biosciences

Former Chief Business Officer

You may also like

Source: SEC filing on March 29, 2019.